E. Dávila

Prevalence and risk factors for metabolic syndrome in Medellin and surrounding municipalities, Colombia, 2008–2010

E. Dávila, Maryi A. Carvajal Quintero, MAITE ORREGO et al. · Preventive Medicine · 2012 · 40 citations

Obesity, Metabolic Syndrome, Epidemiology +10

Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: a Southeastern Cancer Study Group Trial.

Mario J. R. Ravry, G A Omura, Alfred A. Bartolucci et al. · PubMed · 1986 · 31 citations

Phase Ii Evaluation, Hepatology, Medicine +10

Multimodality treatment of non‐small cell lung cancer: Response to cisplatin, VP‐16, and 5‐FU chemotherapy and to surgery and radiation therapy

K. S. Sridhar, Richard J. Thurer, Y. Kim et al. · Journal of Surgical Oncology · 1988 · 28 citations

Surgical Oncology, Adjuvant Chemotherapy, Multimodality +18

Management of locally advanced breast cancer (stage III): a review.

E. Dávila, Charles L. Vogel · PubMed · 1984 · 22 citations

Surgical Oncology, Breast Oncology, Cancer Management +17

A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008

Walter M. Stadler, Susan Halabi, Marc S. Ernstoff et al. · Journal of Clinical Oncology · 2004 · 16 citations

Phase Ii Study, Pharmacotherapy, Pre-clinical Pharmacology +24